Global Retirement Partners LLC Boosts Position in Stryker Corporation $SYK

Global Retirement Partners LLC increased its stake in Stryker Corporation (NYSE:SYK) by 54.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 10,763 shares of the medical technology company’s stock after acquiring an additional 3,802 shares during the quarter. Global Retirement Partners LLC’s holdings in Stryker were worth $3,783,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. United Financial Planning Group LLC purchased a new position in Stryker in the 3rd quarter worth about $27,000. CGC Financial Services LLC purchased a new position in Stryker in the 4th quarter worth about $29,000. Strive Asset Management LLC purchased a new position in Stryker in the 3rd quarter worth about $30,000. ANTIPODES PARTNERS Ltd purchased a new position in Stryker in the 3rd quarter worth about $34,000. Finally, Copia Wealth Management increased its stake in Stryker by 181.6% in the 3rd quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock worth $40,000 after buying an additional 69 shares during the period. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Buying and Selling at Stryker

In other news, VP M Kathryn Fink sold 3,500 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $283.45, for a total value of $992,075.00. Following the sale, the vice president directly owned 177 shares in the company, valued at approximately $50,170.65. This trade represents a 95.19% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 4.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $361.00 price target on shares of Stryker in a research note on Friday, May 1st. Robert W. Baird set a $385.00 price target on shares of Stryker in a research note on Friday, May 1st. Barclays reduced their price target on shares of Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Sanford C. Bernstein set a $410.00 target price on shares of Stryker in a report on Friday, May 1st. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $465.00 target price on shares of Stryker in a report on Wednesday, March 4th. Sixteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $395.48.

Stryker Stock Up 0.9%

NYSE:SYK opened at $316.39 on Friday. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $404.87. The stock has a market capitalization of $121.29 billion, a P/E ratio of 36.62, a P/E/G ratio of 1.98 and a beta of 0.80. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. The company’s 50-day simple moving average is $325.22 and its 200-day simple moving average is $349.82.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The firm had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $6.34 billion. During the same quarter in the prior year, the business posted $2.84 earnings per share. The firm’s quarterly revenue was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, equities analysts anticipate that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio (DPR) is currently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.